1 |
Cunningham D, Allum WH, Stenning SP, et al (2006). Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med, 355, 11-20.
DOI
|
2 |
Cuschieri A, Fayers P, Fielding J, et al (1996). Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomized controlled surgical trial. Lancet, 347, 995-9.
DOI
|
3 |
Cuschieri A, Weeden S, Fielding J, et al (1999). Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Br J Cancer, 79, 1522-30.
DOI
|
4 |
Degiuli M, Sasako M, Ponti A, et al (2004). Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer. Br J Cancer, 90, 1727-32.
|
5 |
Ferlay J, Soerjomataram I, Ervik M, et al (2012). Cancer incidence and mortality worldwide: IARC cancerbase No. 11 [Internet]. Lyon, France: international agency for research on cancer; 2013. Available from: http://globocan.iarc.fr. Accessed April 7, 2014.
|
6 |
Hartgrink HH, van de Velde CJ, Putter H, et al (2004). Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol, 22, 2069-77.
DOI
|
7 |
Howlader NA, Krapcho M, Neyman N, et al (2012). Cancer statistics review, 1975-m2010 (Vintage 2010 Populations). bethesda, MD: national cancer institute. Available from: http://seer.cancer.gov/csr/1975_2010_pops09/.
|
8 |
Maruyama K, Sasako M, Kinoshita T, et al (1995). Pancreaspreserving total gastrectomy for proximal gastric cancer. World J Surg, 19, 532-6.
DOI
|
9 |
Parikh D, Chagla L, Johnson M, et al (1996). D2 gastrectomy: lessons from a prospective audit of the learning curve. Br J Surg, 83, 1595-9.
DOI
|
10 |
Sasako M, Sano T, Yamamoto S, et al (2008). D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med, 359, 453-62.
DOI
|
11 |
Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ (2010). surgical treatment of gaytric camcer:15 Year followup result of the randomissed nationwide Duteh D1D2 trial. Lancet Oncol, 11, 439-49.
DOI
|
12 |
Wanebo HJ, Kennedy BJ, Chmiel J, et al (1993). Cancer of the stomach. a patient care study by the American college of surgeons. Am J Surg, 218, 583-92.
|
13 |
Wu CW, Hsiung CA, Lo SS, et al (2006). Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol, 7, 309-15.
DOI
|
14 |
Yu W, Choi GS, Chung HY (2006). Randomized clinical trial of splenectomy versus splenic preservation in patients with proximal gastric cancer. Br J Surg, 93, 559-63.
DOI
|